Betaine in Patients With Nonalcoholic Steatohepatitis

PHASE2CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

January 31, 2003

Primary Completion Date

June 30, 2006

Study Completion Date

June 30, 2006

Conditions
Nonalcoholic Steatohepatitis
Interventions
DRUG

Cystadane

Betaine 20 mg a day or identical placebo for 1 year.

DRUG

Identical Placebo

Placebo

Trial Locations (2)

32610

University of Florida at Gainesville, Gainesville

55905

Mayo Clinic, Rochester

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

University of Florida

OTHER

collaborator

Orphan Medical

INDUSTRY

lead

Mayo Clinic

OTHER